Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.19%
0%
-7.19%
6 Months
-8.82%
0%
-8.82%
1 Year
55.0%
0%
55.0%
2 Years
-28.9%
0%
-28.9%
3 Years
-52.31%
0%
-52.31%
4 Years
-63.95%
0%
-63.95%
5 Years
-80.38%
0%
-80.38%
China Health Group, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.08%
EBIT Growth (5y)
36.46%
EBIT to Interest (avg)
7.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.59
Tax Ratio
9.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
171.07%
Valuation key factors
Factor
Value
P/E Ratio
5
Industry P/E
Price to Book Value
2.11
EV to EBIT
3.92
EV to EBITDA
3.92
EV to Capital Employed
2.64
EV to Sales
2.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
67.50%
ROE (Latest)
41.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'17 - YoY
Dec'17
Dec'16
Change(%)
Net Sales
35.80
2.50
1,332.00%
Operating Profit (PBDIT) excl Other Income
25.60
-0.60
4,366.67%
Interest
0.00
0.20
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
23.90
-0.10
24,000.00%
Operating Profit Margin (Excl OI)
715.90%
-237.30%
95.32%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2017 is 1,332.00% vs -83.97% in Dec 2016
Consolidated Net Profit
YoY Growth in quarter ended Dec 2017 is 24,000.00% vs 97.96% in Dec 2016
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
28.70
23.70
21.10%
Operating Profit (PBDIT) excl Other Income
-15.40
-64.20
76.01%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-15.70
-64.30
75.58%
Operating Profit Margin (Excl OI)
-552.30%
-2,722.60%
217.03%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 21.10% vs 55.92% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 75.58% vs -249.46% in Dec 2023
About China Health Group, Inc. 
China Health Group, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






